Thursday, 15 October 2026European Markets

Top Startup Nations in Europe in 2022

Loading stream...

Europe's startup scene has recently seen tremendous growth, with several countries serving as hubs of entrepreneurial activity. Estonia, Iceland, Sweden, Switzerland, and United Kingdom all play critical roles in creating vibrant startup ecosystems that support startup activity.

The European startup ecosystem's dynamic and resilient nature is evidence of its innovative spirit, solid infrastructure, and concerted support by governments and investors for European entrepreneurial activity. As this trend evolves, these entrepreneurial hotspots should continue driving growth and innovation within this dynamic market.

  1. Estonia

By 2022, Estonia had more than EUR9800 invested per capita - significantly higher than the European average of just EUR130. Internet use in Estonia is recognized as a fundamental human right and recognized as one of the nation's hallmarks for IT, cybersecurity, and government services. Estonia also boasts over 1400 startups established there, such as Skype, Playtech, Wise & Bolt.

2. Portugal

Lisbon raised approximately EUR780 per capita in 2022. Lisbon-based impact startups raised an astonishing EUR7.8M in 2022 - more than three times what was raised in 2020. The number of local and foreign entrepreneurs and investors entering the region has grown significantly, signaling its healthy development. International investors play an increasingly vital role in Lisbon-based startups' ecosystem, accounting for over 80% of total investments and 70% of rounds raised in 2022. Lisbon's top universities are actively cultivating entrepreneurial talent. Together their combined enterprise value exceeds $850M.

3. Sweden

Swedish companies raised about EUR570 per capita in 2022, significantly exceeding the European average. Sweden has an ecosystem worth EUR239 billion, producing corporations like IKEA or Volvo and unicorn startups such as Klarna and Northvolt.

4. Iceland

Iceland raised approximately EUR500 per capita in 2022, surpassing Europe-wide averages. One hundred sixty-seven startups are present across all sectors - 45 Foodtech startups, 30 Energy & Environment startups, and 18 Health startups.

5. Switzerland

Swiss startups specialize primarily in fintech and blockchain. The average startup funding per capita was approximately EUR440 per capita in 2022.

6. United Kingdom

Investment rates in 2022 are roughly EUR465 per individual in the UK due to its zero startup costs for new business owners and 19% business tax.

7. Czechia

Czechia was named the top country for startups in 2023 due to its low startup costs - just 1.1% of Gross National Income per capita - and a competitive business tax rate of 19%.

8. Finland

Finland stands out with its combination of low 20% corporate tax and average salaries averaging $4,550, scoring the highest score globally for happiness while excelling in quality of life metrics in 2023.

9. Netherlands

In 2023, The Netherlands took top honors for quality of life. Starting costs average 4% of GNI per capita with a 25.8% business tax, and salaries average $3943 per employee.

10. Denmark

Denmark boasts relatively low startup costs at 0.2% of GNI per capita and ranks second for quality of life, boasting the highest average salary in Europe at $5,965 annually - offering highly affordable startup costs for businesses looking to get off the ground quickly.

https://vianews.eu/startup/why-european-member-states-are-still-lagging-behind-the-us-as-startup-leading-nations/
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com